|
|
2G Salvador
![]() Summary for 2004 [at-glance overview of G Salvador work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author G Salvador. According to available data, in 2004 G Salvador published at least 2 articles. This work was completed in collaboration with several authors including Cervera, R and Font, J. Several other authors have collaborated with G Salvador as well. There is no information about the funding or the grants awarded to support this work.
Analysis of the article abstracts and the titles suggests that G Salvador professional interests are focused around "patients primary aps", "hypocomplementemia systemic lupus" and "prevalence clinical significance". These might also be referred to as "primary aps", "livedo reticularis" or "patients primary". Statistical analysis shows that G Salvador's writing is likely to contains terms "patients", "primary", "hypocomplementemia", "aps", "lupus" and "sle".
The majority of G Salvador articles are affiliated with Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain. Sadly, no email addresses were found for any of the affiliations. Images [images we found on the Internet for G Salvador]loading...
Do you know G Salvador who matches the profile above? Click the photo and let us know!
Alternative names (0) [other authors with names similar to G Salvador]Year 2004 Charts [G Salvador frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of G Salvador publication and funding history for the range of years]G Salvador Coauthors (7) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (1) [condensed summary of the G Salvador affiliations, the leading number and the color conveys importance]- 1Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.
Key Opinion Leader In [G Salvador is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]Keywords (21) [keywords assigned to G Salvador articles by PubMed, the leading number and the color conveys importance]- 2Female | 2Humans | 1Neoplasms, Multiple Primary | 1Complement System Proteins | 1Adult | 1Middle Aged | 1Complement C4 | 1Kidney Neoplasms | 1Syndrome | 1Male | 1Prevalence | 1Antiphospholipid Syndrome | 1Flank Pain | 1Morbidity | 1Magnetic Resonance Imaging | 1Angiomyolipoma | 1Complement Hemolytic Activity Assay | 1Retroperitoneal Space | 1Hemorrhage | 1Complement C3 | 1Lupus Erythematosus, Systemic
G Salvador Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; G Salvador might be a good expert witness on these terms]- 8patients | 6primary | 5hypocomplementemia | 5aps | 4lupus | 4sle | 3reticularis | 3livedo | 3clinical | 3syndrome | 3prevalence | 2systemic | 2anti-dsdna | 2erythematosus | 2apl | 2antiphospholipid | 2associated | 2thrombocytopenia | 2follow-up | 2ana | 2features | 2significance | 2higher | 2complement | 2positive | 2accumulated | 1found | 1based | 1flares | 1clearly | 1nderlich | 1nearly
- 4primary aps | 3livedo reticularis | 3patients primary | 2lupus erythematosus | 2reticularis thrombocytopenia | 2hypocomplementemia | 2syndrome prevalence | 2features livedo | 2erythematosus primary | 2patients sle | 2ana anti-dsdna | 2clinical significance | 2systemic lupus | 2prevalence clinical | 2primary antiphospholipid | 2antiphospholipid syndrome | 2hypocomplementemia systemic | 2significance patients | 1patients diagnostic | 1complement factors | 1flares survival | 1immunological markers | 1bilateral renal | 1nderlich | 1nearly half | 1low complement | 1initial manifestation | 1immune-complex mediated | 1values associated | 1related accumulated | 1diagnostic value | 1clearly support
- 3patients primary aps | 2hypocomplementemia systemic lupus | 2prevalence clinical significance | 2hypocomplementemia | 2antiphospholipid syndrome prevalence | 2systemic lupus erythematosus | 2erythematosus primary antiphospholipid | 2syndrome prevalence clinical | 2livedo reticularis thrombocytopenia | 2lupus erythematosus primary | 2features livedo reticularis | 2primary antiphospholipid syndrome | 2clinical significance patients | 1aps higher risk | 1higher risk evolving | 1primary aps presented | 1reticularis hemolytic anemia | 1risk evolving sle | 1sle based association | 1patients diagnostic value | 1thrombocytopenia apl sle-related | 1nderlich | 1igm-acl positive ana | 1based association disease | 1positive ana anti-dsdna | 1aps associated aps | 1diagnostic value hypocomplementemia | 1low complement values | 1survival follow-up years | 1associated aps features | 1anticoagulant positive igm-acl | 1renal angiolipomatosis contrast
Reader's Comments (0) [comments posted by readers of G Salvador profile]Funding (0) [selected NIH grants to G Salvador and the award amounts for recent years]- award information is not available
G Salvador Articles (2) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. (2004) >> Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain. 3Ingelmo, M, 1Campoamor, M T, 1Segura, S, 2Salvador, G, 5Ramos-Casals, M, 2Chamorro, A, 8Font, J, 1Botero, J C, 3Yagüe, J, 8Cervera, R.[Wünderlich syndrome as the initial manifestation of bilateral renal angiolipomatosis] (2004) >> 1Micó, L, 1Calabuir, J R, 2Salvador, G, 1Cervera, J I, 1Tordera, P, 1Montaner, M J.
Science Trivia (2) [Interactive math & science trivia questions]
|
|